top border
top border
Featured Programs

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma
Andrew Ko, MD, professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, provides insight on PEGPH20 for patients with pancreatic adenocarcinoma. View Now

Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now

 

Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Kristi Rosa

Gina Columbus highlights the latest news from the 2019 ASH Annual Meeting in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x